Safety& immunogenicity of intramuscular immunisation with HIV vaccine

• Research type

  Research Study

• Full title

  Phase 1, randomised, single-centre, observer-blind, placebo-controlled trial of safety and immunogenicity of EN41-UGR7C HIV vaccine candidate administered intramuscularly in healthy female volunteers.

• IRAS ID

  122625

• Contact name

  Margaret Johnson

• Contact email

  sally.allen@royalfree.nhs.uk

• Sponsor organisation

  PX’Therapeutics

• Eudract number

  2012-003399-38

• ISRCTN Number

  n/a

• REC name

  London - Hampstead Research Ethics Committee

• REC reference

  13/LO/0132

• Date of REC Opinion

  9 Apr 2013

• REC opinion

  Further Information Favourable Opinion